Plant ID: NPO662
Plant Latin Name: Angelica officinalis
Taxonomy Genus: Angelica
Taxonomy Family: Apiaceae
NCBI TaxonomyDB:
n.a.
Plant-of-the-World-Online:
n.a.
China
TSHR; | |
ACHE; | |
MAPK1; | |
ALOX15; ALDH1A1; | |
NFKB1; | |
SERPINA6; XPO1; LMNA; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 1 | CYP1A2 | Cytochrome P450 1A2 | P05177 | CHEMBL3356 |
Cytochrome P450 family 2 | CYP2A13 | Cytochrome P450 2A13 | Q16696 | CHEMBL3542436 |
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 2 | CYP2D6 | Cytochrome P450 2D6 | P10635 | CHEMBL289 |
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Cytochrome P450 family 2 | CYP2C9 | Cytochrome P450 2C9 | P11712 | CHEMBL3397 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Hydrolase | ACHE | Acetylcholinesterase | P22303 | CHEMBL220 |
Peptide receptor (family A GPCR) | TSHR | Thyroid stimulating hormone receptor | P16473 | CHEMBL1963 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Transcription Factor | NFKB1 | Nuclear factor NF-kappa-B p105 subunit | P19838 | CHEMBL3251 |
Unclassified | SERPINA6 | Corticosteroid binding globulin | P08185 | CHEMBL2421 |
Unclassified | XPO1 | Exportin-1 | O14980 | CHEMBL5661 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
BP | GO:0050896; response to stimulus | GO:0042738; exogenous drug catabolic process | 1.540E-13 | 8.381E-10 | CYP1A2, CYP2A6, CYP2C19, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0008395; steroid hydroxylase activity | 1.476E-13 | 8.381E-10 | CYP2A13, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0005506; iron ion binding | 2.261E-13 | 9.845E-10 | ALOX15, CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
MF | GO:0005488; binding | GO:0019825; oxygen binding | 8.893E-13 | 2.152E-09 | CYP1A2, CYP2A13, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0019373; epoxygenase P450 pathway | 3.939E-12 | 7.147E-09 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2C9 |
MF | GO:0005488; binding | GO:0020037; heme binding | 5.176E-12 | 8.669E-09 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0070989; oxidative demethylation | 1.547E-10 | 1.872E-07 | CYP1A2, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006805; xenobiotic metabolic process | 2.824E-10 | 2.928E-07 | CYP1A2, CYP2A13, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 5.326E-10 | 5.042E-07 | CYP1A2, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, SERPINA6 |
MF | GO:0003824; catalytic activity | GO:0008392; arachidonic acid epoxygenase activity | 7.422E-10 | 6.216E-07 | CYP2A13, CYP2A6, CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0034875; caffeine oxidase activity | 1.864E-09 | 1.320E-06 | CYP1A2, CYP2C9, CYP3A4 |
MF | GO:0003824; catalytic activity | GO:0070330; aromatase activity | 2.753E-09 | 1.873E-06 | CYP1A2, CYP2A13, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0009804; coumarin metabolic process | 1.629E-08 | 9.585E-06 | CYP2A13, CYP2A6, CYP2D6 |
BP | GO:0008152; metabolic process | GO:0097267; omega-hydroxylase P450 pathway | 5.576E-08 | 3.035E-05 | CYP1A2, CYP2C19, CYP2C9 |
MF | GO:0003824; catalytic activity | GO:0008389; coumarin 7-hydroxylase activity | 6.433E-07 | 3.183E-04 | CYP2A13, CYP2A6 |
BP | GO:0008152; metabolic process | GO:0009822; alkaloid catabolic process | 1.929E-06 | 9.131E-04 | CYP2D6, CYP3A4 |
CC | GO:0016020; membrane | GO:0005789; endoplasmic reticulum membrane | 4.290E-06 | 1.946E-03 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0042445; hormone metabolic process | 1.355E-05 | 5.785E-03 | ACHE, ALDH1A1, CYP3A4, SERPINA6 |
BP | GO:0008152; metabolic process | GO:0016098; monoterpenoid metabolic process | 1.170E-15 | 2.547E-11 | CYP1A2, CYP2C19, CYP2C9, CYP2D6, CYP3A4 |
CC | GO:0016020; membrane | GO:0031090; organelle membrane | 9.494E-05 | 3.692E-02 | CYP1A2, CYP2A13, CYP2A6, CYP2C19, CYP2C9, CYP2D6, CYP3A4, LMNA, XPO1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 1.052E-11 | 8.084E-10 | CYP2C9, CYP2A6, CYP2D6, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 1.491E-11 | 8.084E-10 | CYP2C9, CYP2A6, CYP2A13, CYP2D6, CYP1A2, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 1.925E-11 | 8.084E-10 | CYP2C9, CYP1A2, ALOX15, CYP3A4, CYP2C19 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 3.056E-11 | 9.625E-10 | CYP2C9, CYP2A6, CYP2A13, CYP1A2, CYP3A4, CYP2C19 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 1.317E-09 | 3.319E-08 | CYP2C9, CYP2A6, CYP1A2, ALDH1A1, CYP3A4 |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 2.093E-08 | 4.396E-07 | CYP2C9, CYP2D6, ALOX15, MAPK1, CYP2C19 |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 2.398E-05 | 3.358E-04 | CYP2C9, CYP2A6, CYP1A2, ALOX15, ALDH1A1, CYP2C19, CYP3A4 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 1.544E-05 | 2.431E-04 | CYP2C9, ALOX15, CYP2C19 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 1.759E-04 | 2.216E-03 | LMNA, MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05164 | Influenza A | 3.391E-04 | 3.884E-03 | XPO1, MAPK1, NFKB1 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04024 | cAMP signaling pathway | 4.939E-04 | 5.186E-03 | MAPK1, NFKB1, TSHR |
09160 Human Diseases | 09161 Cancers | hsa05221 | Acute myeloid leukemia | 9.334E-04 | 7.609E-03 | MAPK1, NFKB1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 6.084E-04 | 5.897E-03 | CYP2A6, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05212 | Pancreatic cancer | 1.249E-03 | 8.737E-03 | MAPK1, NFKB1 |
09150 Organismal Systems | 09152 Endocrine system | hsa04917 | Prolactin signaling pathway | 1.484E-03 | 8.737E-03 | MAPK1, NFKB1 |
09150 Organismal Systems | 09151 Immune system | hsa04621 | NOD-like receptor signaling pathway | 9.334E-04 | 7.609E-03 | MAPK1, NFKB1 |
09150 Organismal Systems | 09151 Immune system | hsa04662 | B cell receptor signaling pathway | 1.526E-03 | 8.737E-03 | MAPK1, NFKB1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00140 | Steroid hormone biosynthesis | 9.663E-04 | 7.609E-03 | CYP1A2, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05220 | Chronic myeloid leukemia | 1.526E-03 | 8.737E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05140 | Leishmaniasis | 1.526E-03 | 8.737E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05131 | Shigellosis | 1.212E-03 | 8.737E-03 | MAPK1, NFKB1 |
09160 Human Diseases | 09167 Infectious diseases | hsa05133 | Pertussis | 1.609E-03 | 8.816E-03 | MAPK1, NFKB1 |
09100 Metabolism | 09110 Biosynthesis of other secondary metabolites | hsa00232 | Caffeine metabolism | 5.992E-06 | 1.079E-04 | CYP2A6, CYP1A2 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|